Clinical Trials Browser

Phase 2 × CTL019 chimeric antigen receptor × Other hematologic neoplasm × Clear all

NCT04778579 2024-06-26

CART19-BE-02

Phase 2 Active not recruiting

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma